Looking beyond bronchopulmonary dysplasia: prematurity-associated lung disease and its phenotypes

Christopher William Course1, Andrew Bush2, Sailesh Kotecha1

  • 1Department of Child Health, School of Medicine, Cardiff University, Cardiff, UK.

PubMed

Insights

Preterm birth is a key factor in chronic respiratory diseases. This study introduces prematurity-associated lung disease (PLD) as a framework to understand diverse lung issues in preterm infants, aiding personalized care.

Area of Science:

  • Pulmonology
  • Neonatology
  • Pediatric Respiratory Medicine

Background:

  • Preterm birth is a significant risk factor for chronic respiratory diseases throughout life.
  • Historically, focus has been on extremely preterm infants and bronchopulmonary dysplasia (BPD), but other preterm groups also face lung disease risks.
  • Factors beyond BPD, including gestational age and intrauterine growth restriction, contribute to lung disease in preterm infants.

Purpose of the Study:

  • To introduce prematurity-associated lung disease (PLD) as a unifying concept for pulmonary consequences of preterm birth.
  • To highlight diverse PLD phenotypes beyond traditional BPD.
  • To establish a foundation for personalized monitoring and targeted therapies for preterm infants with lung disease.

Main Methods:

  • Review and synthesis of existing literature on lung disease following preterm birth.
  • Identification and characterization of distinct prematurity-associated lung disease phenotypes.
  • Analysis of contributing factors and prognostic implications for each phenotype.

Main Results:

  • Preterm birth is a determinant of chronic respiratory disease across the lifespan.
  • Multiple phenotypes of prematurity-associated lung disease (PLD) exist, including obstructive lung disease, preserved ratio impaired spirometry, and dysanapsis.
  • These phenotypes are linked to specific early-life exposures and mechanisms, impacting prognosis differently.

Conclusions:

  • PLD provides a comprehensive framework for understanding the spectrum of lung disease in preterm infants.
  • Recognizing distinct PLD phenotypes is crucial for developing individualized management strategies.
  • Further research into these phenotypes will enable more precise monitoring and therapeutic interventions for affected children.

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
2.9K
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
64.1K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
543